Navigation Links
Eurofins MWG Operon’s Express Oligos Provide Faster Than Ever Service

(PRWEB) February 06, 2013

Expanding on the mission to deliver ISO-quality research products and services ‘faster than ever,’ Eurofins MWG Operon announces their entry into the overnight oligonucleotide market. The new Express Oligo service can be ordered as late as 4:00 p.m. ET for delivery by 10:30 the next morning. As research projects often require oligo synthesis based on the latest experimental results, customers throughout the US can rely on Eurofins MWG Operon to accept orders an hour later than other oligo providers.

“With this new and very inexpensive service we further strengthen our position to be the fastest DNA Company in the US. We currently offer overnight DNA sequencing for all US locations and now the fastest oligo service in the industry for the US,” stated Martin Kunz, CEO of Eurofins MWG Operon Inc. “The new Express Oligo service benefits the research of any institution or company pursuing development in fast cycles, as we now offer primer synthesis and DNA sequencing - both in less than 24 hours and faster than any competitor.”

“Process improvements and optimized logistics make faster delivery possible and also ensure Express Oligos undergo the same ISO-certified quality tests as our standard oligos.” stated Dr. Philipp Wenter, VP Manufacturing of Eurofins MWG Operon Inc. “We provide a clear research advantage since we are the only manufacturer that does full QC on overnight oligos, including Mass-Spec, before shipment. All of our oligos are produced under ISO 9001/13485 specifications.”

Visit for more information about overnight oligo synthesis services.

About Eurofins MWG Operon
Eurofins MWG Operon, a member of the Eurofins Group with major offices and production facilities in the United States, Europe, and Asia, is an international provider of DNA sequencing services, DNA synthesis products, and bioinformatics services for academic and industrial research. The company’s strengths are its strong customer orientation, fast service, and high quality. For additional information, please visit our website at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
2. transOMIC technologies Releases Tagged ORF Clones for Protein Expression
3. Antigen Express AE37 Breast Cancer Vaccine Featured In "Micro-Cap Review" Interview
4. Exon skipping to restore gene expression is promising therapeutic strategy for muscular dystrophy
5. Genedata Expressionist® Established as Data Analysis Platform for Oncological Research
6. HemoShear Partners with Expression Analysis (EA) to Develop a Human Drug-Induced Vascular Response Database
7. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
8. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
9. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
10. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
11. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
Post Your Comments:
(Date:11/30/2015)... -- Champions Oncology, Inc. (CSBR), engaged in the development of ... and use of oncology drugs, today announced that ... at the LD MICRO Investor Conference on Wednesday, December ... conference, held at the Luxe Sunset Bel Air Hotel ... feature 200 small/micro-cap companies and is expected to host ...
(Date:11/30/2015)...  HUYA Bioscience International, the leader in accelerating global ... today announced it has signed a Memorandum of Understanding ... collaboration between KDDF and HUYA with the ultimate goal ... for the global market. China,s ... innovative preclinical and clinical stage compounds. The company advances ...
(Date:11/30/2015)... Germany , November 30, 2015 ... Vienna, Austria to be held December 1-4, ... in Vienna, Austria to be ... owned subsidiary of Vycor Medical, Inc. ("Vycor") (OTCQB: VYCO), announced ... Therapy Suite at the 3rd European Congress of NeuroRehabilitation ...
(Date:11/30/2015)... and PETACH TIKVAH, Israel , Nov. 30, ... BCLI ), a leading developer of adult stem cell technologies ... Cell Therapeutics Ltd., has been awarded an additional grant of ... the Chief Scientist (OCS). This grant, the second this year, ... activities to approximately $1.8 million (approximately NIS7 million).  ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
(Date:11/12/2015)... BOSTON , Nov. 12, 2015  A golden ... for Duchenne muscular dystrophy (DMD) has provided a new ... Boston Children,s Hospital, the Broad Institute of MIT and ... Brazil . Cell, ... some dogs "escape" the disease,s effects. The Boston Children,s ...
(Date:11/11/2015)... 2015   MedNet Solutions , an innovative SaaS-based eClinical ... is pleased to announce that it will be a Sponsor ... event, to be held November 17-19 in Hamburg ... demonstrations of iMedNet , MedNet,s easy-to-use, proven ... has been able to deliver time and cost savings ...
Breaking Biology News(10 mins):